%0 Journal Article
%T Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
%A Ayaka Inada
%A Iku Niinomi
%A Kazunori Iwanaga
%A Keiko Hosohata
%A Mayako Uchida
%A Saki Oyama
%A Yasuhiro Mori
%A Yuki Yamaguchi
%J Archive of "Therapeutics and Clinical Risk Management".
%D 2019
%R 10.2147/TCRM.S176620
%X Bisphosphonates (BPs) and denosumab are widely used to treat osteoporosis and complications associated with bone metastases. However, medication-related osteonecrosis of the jaw (MRONJ) is a serious problem
%K medication-related osteonecrosis of the jaw
%K pharmacovigilance
%K spontaneous reporting system
%K reporting odds ratio
%K Japanese Adverse Drug Event Report database
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307679/